Distribution and Characteristics of Pulmonary Neuroendocrine Tumors: Single Institution Experience in Lebanon

  • Kesrouani, Carole (Pathology Department, Faculty of Medicine, Saint Joseph University) ;
  • Ghorra, Claude (Pathology Department, Faculty of Medicine, Saint Joseph University) ;
  • Rassy, Marc (Pathology Department, Faculty of Medicine, Saint Joseph University) ;
  • Kourie, Hampig Raphael (Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University) ;
  • Kattan, Joseph (Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University)
  • Published : 2016.05.01


Background: Neuroendocrine tumors represent 20% of primary lung neoplasms in some registries. According to the WHO classification of 2004, reconsidered for 2015, these lung tumors are divided into 4 groups: typical and atypical carcinoid, small cell and large cell neuroendocrine carcinomas. We report in this paper, for the first time in Lebanon, the distribution and the population characteristics of these tumors. Materials and Methods: This descriptive retrospective study concerned all the pulmonary neuroendocrine tumors (NET) with their characteristics diagnosed in $H\hat{o}tel$ Dieu de France in Beirut, Lebanon from 2001 to 2012, with attention to features like age, gender and subgroup. Results: Of 194 patients with pulmonary NET, 12.4% were typical carcinoid tumors, 3.6% atypical carcinoid, 66.5% small cell lung cancer, 7.7% combined small cell carcinomas and 9.8% large cell neuroendocrine tumors. The mean ages of patients were respectively 51.2 years in typical carcinoid, 64 years in atypical carcinoid, 64.2 years in small cell lung cancers, 67.2 in combined small cell lung cancer and 66.9 in large cells neuroendocrine tumors. The M/F sex ratios were respectively 0.3, 1.3, 1.4, 2.7 and 2.2. Conclusions: The characteristics of lung neuroendocrine tumors in our Lebanese institution are comparable to those reported in the literature.




  1. Aslan DL, Gulbahce HE, Pambuccian SE et al (2005). Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasms in specimens with extensive crush artifact. Am J Clin Pathol, 123, 874-78.
  2. Davini F, Gonfiotti A, Comin C et al (2009). Typical and atypical carcinoid tumours: 20-year experience with 89 patients. J Cardiovasc Surg (Torino). 50, 807-11.
  3. Fink G, Krelbaum T, Yellin A et al (2001). Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest, 119, 1647-51.
  4. Fisseler-Eckhoff A, Demes M (2012). Neuroendocrine tumors of the lung. Cancers (Basel). 4, 777-98.
  5. Gustafsson BI, Kidd M, Chan A, Malfertheiner MV et al (2008). Bronchopulmonary neuroendocrine tumors. Cancer. 113, 5-21.
  6. Herde RF, Kokeny KE, Reddy CB et al (2015). Primary Pulmonary Carcinoid Tumor: A Long-term Single Institution Experience. Am J Clin Oncol. [Epub ahead of print]
  7. Kourie HR, Rassy M, Ghorra C et al (2015). Histologic distribution of pulmonary tumors in Lebanon: a 5-year single institution experience. Asian Pac J Cancer Prev. 16, 5899-902.
  8. Rekhtman N (2010). Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med, 134, 1628-38
  9. Skuladottir H, Hirsch FR, Hansen HH et al (2002). Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer, 37, 127-35.
  10. Travis WD, Brambilla E, Muller-Hermelink HK et al (2004). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC